We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Series of preclinical studies demonstrate the therapeutic potential of PAT-DX1, a first-in-class, synthetically lethal DNA-binding antibody in primary brain cancers and brain metastases. Patrys...
PAT-SM6 clinical trial data from all 4 cohorts to be presented at prestigious American Society of Hematology conference From 11 currently evaluable patients, 4 (36%) experienced stable...
Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1 - Laureate Biopharmaceutical Services to manufacture lead product PAT-LM1 Appointment follows Laureate exceeding yield...
NEW YORK, May 24 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today began trading Citigroup Funding Inc.'s PACERS Linked to eBay Inc. Priced at $10.00 per unit with an initial offer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.001 | 16.6666666667 | 0.006 | 0.0075 | 0.006 | 862202 | 0.00685442 | DE |
4 | 0.001 | 16.6666666667 | 0.006 | 0.0075 | 0.005 | 578606 | 0.00655878 | DE |
12 | 0 | 0 | 0.007 | 0.008 | 0.005 | 881410 | 0.00679157 | DE |
26 | -0.003 | -30 | 0.01 | 0.01 | 0.005 | 1042159 | 0.00765141 | DE |
52 | -0.001 | -12.5 | 0.008 | 0.011 | 0.005 | 1190707 | 0.00799288 | DE |
156 | -0.032 | -82.0512820513 | 0.039 | 0.0475 | 0.005 | 2583973 | 0.02488209 | DE |
260 | -0.016 | -69.5652173913 | 0.023 | 0.063 | 0.005 | 4220597 | 0.02965844 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions